Frontiers in Cardiovascular Medicine

AUGUST 7, 2024

Aortic Stenosis (AS) is a common condition with an estimated pooled prevalence of all AS in the elderly population at around 12.4%, with that of severe AS estimated to be around 3.4%. Therefore, alternative TAVR approaches have gained increasing utility in cases where transfemoral access is unfavorable.

Aortic valve 98

Aortic valve Aortic TAVR Peripheral Arterial Disease 98

Frontiers in Cardiovascular Medicine

APRIL 24, 2024

With this longer lifespan, calcific aortic stenosis (AS) was identified as an emerging critical risk factor for cardiac death in older patients. Modified transcatheter aortic valve replacement (TAVR) and left ventricular Apico-Aortic Conduit (AAC) placement were deemed high risk but viable options. years by 4.3

Stenosis 52

Stenosis Aortic Peripheral Arterial Disease TAVR 52

Frontiers in Cardiovascular Medicine

APRIL 7, 2024

Transcatheter aortic valve replacement (TAVR) has increasingly become a safe, feasible, and widely accepted alternative surgical treatment for patients with severe symptomatic aortic stenosis.

Aortic valve 52

Aortic valve Aortic TAVR Risk Factors 52

Frontiers in Cardiovascular Medicine

DECEMBER 13, 2023

Transcatheter aortic valve replacement (TAVR) is a relatively new treatment method for aortic stenosis (AS) and has been demonstrated to be suitable for patients with varying risk levels.

Aortic valve 64

Aortic valve Cardiac Rehabilitation Aortic TAVR 64

Circulation

OCTOBER 25, 2023

Background:The optimal treatment in patients with severe aortic stenosis (AS) and small aortic annulus (SAA) remains to be determined. Participants were 151 patients with severe AS and SAA (mean diameter <23 mm) were randomized (1:1) to TAVR (n=77) vs SAVR (n=74), The primary outcome was impaired valve hemodynamics (i.e.

Aortic valve 40

Aortic valve Aortic TAVR Stenosis 40

DAIC

FEBRUARY 29, 2024

24: Joint American College of Cardiology/Journal of the American College of Cardiology Late-Breaking Clinical Trials (Session 402) Saturday, April 6 9:30 – 10:30 a.m. ET Murphy Ballroom 4 ACC.24 24 planners note that attendees can gain insights from key clinical trials presented at ACC.24

Aortic valve 103

Aortic valve Myocardial Infarction Aortic Blood Pressure 103

Cardiology Update

JANUARY 31, 2024

Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for older patients suffering from severe aortic valve stenosis, surpassing the annual patient count of those opting for surgical aortic valve replacement. Despite this, bleeding remains one of the most common complications associated with TAVR.

TAVR 118

TAVR Aortic valve Outcomes Aortic 118